Sun Yat-sen University Cancer Center
Clinical trials sponsored by Sun Yat-sen University Cancer Center, explained in plain language.
-
Could a common antibiotic boost chemo for tough breast cancer?
Disease control Recruiting nowThis phase 3 trial is testing whether adding the antibiotic moxifloxacin to standard chemotherapy (gemcitabine and carboplatin) helps people with metastatic triple-negative breast cancer live longer without their cancer growing. About 228 participants will receive either the anti…
Phase: PHASE3 • Sponsor: Sun Yat-Sen University Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New combo therapy aims to control brain tumors in lung cancer patients
Disease control Recruiting nowThis study tests whether adding the drug bevacizumab to a precise type of radiation therapy (fractionated stereotactic radiotherapy) can better control multiple brain tumors that have spread from lung adenocarcinoma. About 258 adults with 1 to 20 brain metastases will take part. …
Phase: PHASE3 • Sponsor: Sun Yat-Sen University Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC